Phibro Animal Health Corporation Reports Third Quarter

Go back to Phibro Animal Health Corporation Reports Third Quarter

Guggenheim Remains Positive on Phibro Animal Health (PAHC), Raises Price Target to $40

May 12, 2015 11:34 AM EDT

Guggenheim maintains a Buy rating on Phibro Animal Health Corp. (NASDAQ: PAHC), and raised the price target to $40.00 (from $35.00), following F3Q15 beat. PAHC reported an adjusted diluted EPS of $0.41 ($0.05 higher than consensus and $0.07 better than Guggenheim estimate). PAHC management raised the '15 EPS guidance from... More

Phibro Animal Health (PAHC) Declares $0.10 Quarterly Dividend; 1.2% Yield

May 11, 2015 4:52 PM EDT

Phibro Animal Health (NASDAQ: PAHC) declared a quarterly dividend of $0.10 per share, or $0.4 annualized.

The dividend will be payable on June 24, 2015, to stockholders of record on June 3, 2015, with an ex-dividend date of June 1, 2015.

The annual yield on the dividend is 1.2... More

Phibro Animal Health (PAHC) Tops Q3 EPS by 5c; Guides FY15 EPS Above Expectations

May 11, 2015 4:51 PM EDT

Phibro Animal Health (NASDAQ: PAHC) reported Q3 EPS of $0.41, $0.05 better than the analyst estimate of $0.36. Revenue for the quarter came in at $187 million versus the consensus estimate of $187.8 million.

Phibro Animal Health sees FY2015 EPS of $1.65-$1.67, versus the consensus of $1.62. Phibro Animal... More